Soleus Capital Management as of Dec. 31, 2024
Portfolio Holdings for Soleus Capital Management
Soleus Capital Management holds 81 positions in its portfolio as reported in the December 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Spdr Ser Tr S&p Biotech Call Option (XBI) | 17.0 | $270M | 3.0M | 90.06 | |
| Novocure Ord Shs (NVCR) | 5.1 | $82M | 2.7M | 29.80 | |
| Tg Therapeutics (TGTX) | 5.1 | $81M | 2.7M | 30.10 | |
| BioMarin Pharmaceutical (BMRN) | 4.1 | $66M | 1.0M | 65.73 | |
| Krystal Biotech (KRYS) | 3.5 | $56M | 358k | 156.66 | |
| Grifols S A Sp Adr Rep B Nvt (GRFS) | 3.1 | $49M | 6.6M | 7.44 | |
| Axogen (AXGN) | 3.1 | $49M | 3.0M | 16.48 | |
| Iovance Biotherapeutics (IOVA) | 3.1 | $49M | 6.6M | 7.40 | |
| Teva Pharmaceutical Inds Sponsored Ads (TEVA) | 2.9 | $46M | 2.1M | 22.04 | |
| Terns Pharmaceuticals (TERN) | 2.8 | $45M | 8.1M | 5.54 | |
| Organogenesis Hldgs (ORGO) | 2.5 | $40M | 13M | 3.20 | |
| Nurix Therapeutics (NRIX) | 2.5 | $40M | 2.1M | 18.84 | |
| United Therapeutics Corporation (UTHR) | 2.4 | $39M | 109k | 352.84 | |
| Celcuity (CELC) | 2.1 | $34M | 2.6M | 13.09 | |
| Syndax Pharmaceuticals (SNDX) | 2.1 | $33M | 2.5M | 13.22 | |
| Jasper Therapeutics Com New (JSPR) | 2.0 | $32M | 1.5M | 21.38 | |
| Integra Lifesciences Hldgs C Com New (IART) | 1.8 | $29M | 1.3M | 22.68 | |
| Neuropace (NPCE) | 1.7 | $27M | 2.4M | 11.19 | |
| Astrazeneca Sponsored Adr (AZN) | 1.7 | $27M | 409k | 65.52 | |
| C4 Therapeutics Com Stk (CCCC) | 1.6 | $25M | 7.0M | 3.60 | |
| Quidel Corp (QDEL) | 1.5 | $24M | 547k | 44.55 | |
| Insmed Com Par $.01 (INSM) | 1.4 | $22M | 320k | 69.04 | |
| Inhibikase Therapeutics Com New (IKT) | 1.3 | $21M | 6.3M | 3.25 | |
| Ascendis Pharma A/s Sponsored Adr (ASND) | 1.2 | $20M | 144k | 137.67 | |
| Rigel Pharmaceuticals (RIGL) | 1.2 | $19M | 1.1M | 16.82 | |
| Praxis Precision Medicines I Com New (PRAX) | 1.2 | $19M | 244k | 76.96 | |
| Alnylam Pharmaceuticals (ALNY) | 1.1 | $18M | 77k | 235.31 | |
| Adaptive Biotechnologies Cor (ADPT) | 1.1 | $18M | 3.0M | 6.00 | |
| Edap Tms S A Sponsored Adr (EDAP) | 1.0 | $16M | 7.3M | 2.21 | |
| Takeda Pharmaceutical Sponsored Ads (TAK) | 1.0 | $16M | 1.2M | 13.24 | |
| Pharvaris N V (PHVS) | 1.0 | $16M | 815k | 19.17 | |
| SurModics (SRDX) | 1.0 | $16M | 394k | 39.60 | |
| Septerna (SEPN) | 1.0 | $16M | 675k | 22.90 | |
| Merus N V (MRUS) | 0.8 | $13M | 312k | 42.05 | |
| Orthofix Medical (OFIX) | 0.8 | $12M | 686k | 17.46 | |
| Biosante Pharmaceuticals (ANIP) | 0.7 | $11M | 205k | 55.28 | |
| Verastem Com New (VSTM) | 0.7 | $11M | 2.2M | 5.17 | |
| Protagonist Therapeutics (PTGX) | 0.7 | $11M | 275k | 38.60 | |
| Delcath Sys Com New (DCTH) | 0.6 | $9.6M | 801k | 12.04 | |
| Cg Oncology (CGON) | 0.6 | $9.4M | 329k | 28.68 | |
| Arcellx Common Stock (ACLX) | 0.6 | $9.3M | 121k | 76.69 | |
| Eli Lilly & Co. (LLY) | 0.6 | $9.0M | 12k | 772.00 | |
| Revolution Medicines (RVMD) | 0.6 | $8.8M | 201k | 43.74 | |
| Theratechnologies Com New | 0.5 | $8.7M | 4.8M | 1.81 | |
| Nuvalent Inc-a (NUVL) | 0.5 | $8.2M | 104k | 78.28 | |
| Vaxcyte (PCVX) | 0.5 | $8.1M | 99k | 81.86 | |
| Evolus (EOLS) | 0.5 | $7.7M | 697k | 11.04 | |
| Immunic (IMUX) | 0.5 | $7.3M | 7.3M | 1.00 | |
| Scholar Rock Hldg Corp (SRRK) | 0.5 | $7.2M | 168k | 43.22 | |
| Castle Biosciences (CSTL) | 0.4 | $6.7M | 253k | 26.65 | |
| Myomo Com New (MYO) | 0.4 | $5.8M | 900k | 6.44 | |
| Anaptysbio Inc Common (ANAB) | 0.3 | $5.5M | 414k | 13.24 | |
| Erasca (ERAS) | 0.3 | $5.4M | 2.2M | 2.51 | |
| Edgewise Therapeutics (EWTX) | 0.3 | $4.9M | 183k | 26.70 | |
| Vericel (VCEL) | 0.3 | $4.4M | 81k | 54.91 | |
| Crinetics Pharmaceuticals In (CRNX) | 0.3 | $4.3M | 85k | 51.13 | |
| Essa Pharma Com New (EPIX) | 0.3 | $4.0M | 2.3M | 1.79 | |
| Inspiremd (NSPR) | 0.2 | $3.6M | 1.4M | 2.63 | |
| Rocket Pharmaceuticals (RCKT) | 0.2 | $3.4M | 272k | 12.57 | |
| Madrigal Pharmaceuticals (MDGL) | 0.2 | $3.4M | 11k | 308.57 | |
| Replimune Group (REPL) | 0.2 | $3.2M | 263k | 12.11 | |
| Apogee Therapeutics (APGE) | 0.2 | $3.2M | 70k | 45.30 | |
| Calcimedica Com New (CALC) | 0.2 | $2.8M | 784k | 3.54 | |
| Mereo Biopharma Group Spon Ads (MREO) | 0.2 | $2.8M | 787k | 3.50 | |
| Y Mabs Therapeutics | 0.2 | $2.7M | 350k | 7.83 | |
| Establishment Labs Holdings Ord (ESTA) | 0.2 | $2.7M | 59k | 46.07 | |
| Bausch Plus Lomb Corp Common Shares (BLCO) | 0.1 | $2.2M | 121k | 18.06 | |
| Mdxhealth Sa Shs New (MDXH) | 0.1 | $2.0M | 852k | 2.37 | |
| Enliven Therapeutics (ELVN) | 0.1 | $1.7M | 75k | 22.50 | |
| Regeneron Pharmaceuticals (REGN) | 0.1 | $1.6M | 2.3k | 712.33 | |
| Tectonic Therapeutic (TECX) | 0.1 | $1.5M | 32k | 46.17 | |
| Adverum Biotechnologies Com New (ADVM) | 0.1 | $1.3M | 287k | 4.67 | |
| Aadi Bioscience (WHWK) | 0.1 | $1.1M | 333k | 3.15 | |
| Abivax Sa Sponsored Ads (ABVX) | 0.1 | $915k | 125k | 7.32 | |
| Miragen Therapeutics (VRDN) | 0.1 | $872k | 46k | 19.17 | |
| GSK Sponsored Adr (GSK) | 0.0 | $342k | 10k | 33.82 | |
| Genedx Holdings Corp Com Cl A (WGS) | 0.0 | $307k | 4.0k | 76.86 | |
| Tenet Healthcare Corp Com New (THC) | 0.0 | $256k | 2.0k | 126.23 | |
| Beigene Sponsored Adr (ONC) | 0.0 | $212k | 1.2k | 184.71 | |
| Anthem (ELV) | 0.0 | $203k | 550.00 | 368.90 | |
| Io Biotech (IOBT) | 0.0 | $177k | 193k | 0.92 |
